Purpose

The overall goal of this study is to attempt to overcome the organizational barriers that impede prompt screening for at-risk sensory deficits in childhood cancer survivors (CCS). Using a cross sectional design study, collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the highlighting patients at risk for sensory screening (HPARSS) document. The investigators will utilize the HPARSS that will link therapy related risks for sensory deficits to specific screening procedures prompting the primary oncology provider to implement screening, diagnostic testing, and therapy.

Condition

Eligibility

Eligible Ages
Between 7 Years and 17 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with a diagnosis of pediatric cancer (diagnosis at <18 years of age) - Treatment including chemotherapy and/or radiation therapy - Completion of all cancer therapy for at least 6 months and less than 2 years - Followed in the Division of Pediatric Hematology/Oncology Program at the Washington University School of Medicine - Current age between 7 and 17 years of age (age where all of the screening tests are both valid and have been successfully performed by our group) - English speaking

Exclusion Criteria

  • Undergoing active cancer treatment - Patient under the care of the Late Effects Program at St. Louis Children's Hospital - Received previous diagnostic testing or rehabilitative therapy for a secondary deficit eligible for screening. - Parents and/or patient illiteracy - No contact with treatment team in the past two years - In foster care or without a legal guardian

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Non-Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Health Services Research
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Patients: Highlighting Patients at Risk for Sensory Screening (HPARSS)
- The primary oncology team will utilize the HPARSS to identify patients who are at risk for sensory deficits based on prior treatment. The HPARSS will constitute a file of that will contain eligible patients based upon their past treatment and their corresponding risk for a particular sensory deficit based upon that treatment. The patient and parent/guardian will be approached to participate in the study. - Sensory deficit screening will be completed in the clinic and any screening results that indicate the need for referral for diagnostic testing or therapy will be scheduled by the primary treatment team staff.
  • Other: Highlighting Patients at Risk for Sensory Screening (HPARSS)
    Collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the HPARSS document.
No Intervention
Providers: Highlighting Patients at Risk for Sensory Screening (HPARSS)
-Providers will complete a survey regarding their views of the HPARSS. The Acceptability of Intervention Measure has 4 questions and the Feasibility of Intervention Measure has 4 questions.

Recruiting Locations

Washington University in St. Louis and nearby locations

St. Louis Children's Hospital - Washington University School of Medicine
St Louis 4407066, Missouri 4398678 63110
Contact:
Robert J Hayashi, M.D.
314-454-6018
hayashi_r@wustl.edu

More Details

NCT ID
NCT05582551
Status
Recruiting
Sponsor
Washington University School of Medicine

Study Contact

Robert J Hayashi, M.D.
314-454-6018
hayashi_r@wustl.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.